Global Pharmaceuticals & Medicine Manufacturing Market Size to Exceed USD 1.31 Trillion by 2035| CAGR of 0.88%
Category: HealthcareAccording to a research report published by Spherical Insights & Consulting, The Global Pharmaceuticals & Medicine Manufacturing Market Size is Expected To Grow from USD 1.19 Trillion in 2024 to USD 1.31 Trillion by 2035, at a CAGR of 0.88% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Pharmaceuticals & Medicine Manufacturing Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Oncologics & Autoimmune, Hypertension & Diabetes, Antiulcerants & Pain, Dermatology & Antibiotics, and Other), By Major Market (Consumers in Developed Markets, Consumers in Pharmerging Markets, and Consumers in the Rest of the World), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/pharmaceuticals-and-medicine-manufacturing-market
The pharmaceuticals & medicine manufacturing market is the industry involving the large-scale creation of active medicinal substances and finished pharmaceutical products, from raw materials to packaging. Pharmaceutical & medicine manufacturing involves the process of industrial-scale synthesis of pharmaceutical drugs as part of the pharmaceutical industry. Single-use disposable solutions are popularly used in pharmaceuticals & medicine manufacturing, along with the changing inclination towards paperless operations with interconnected, intelligent, and data-rich operations. Trend toward personalized medicine, driving the need for specialized manufacturing processes, thereby bolstering the market growth opportunity. The increasing health & wellness awareness and technological advancements are driving the market growth. However, the stringent regulatory policies and patent expiration, and supply chain disruption are challenging the market.
The oncologics & autoimmune segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product & service, the Pharmaceuticals & Medicine Manufacturing market is divided into oncologics & autoimmune, hypertension & diabetes, antiulcerants & pain, dermatology & antibiotics, and other. Among these, the oncologics & autoimmune segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Oncologics and autoimmune disease drugs are used for the treatment of inflammatory and autoimmune diseases. The extensive research on novel therapies, such as targeted treatments and immunotherapy, is driving the market growth.
The consumers in developed countries segment accounted for a major share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the major market, the pharmaceuticals & medicine manufacturing market is divided into consumers in developed markets, consumers in pharmerging markets, and consumers in the rest of the world. Among these, the consumers in developed countries segment accounted for a major share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. There is increasing focus on developing personalized medicine and advanced technologies like bedside & portable manufacturing in the developed regions. Further, increased accessibility of healthcare services and investment in effective medical facilities contribute to propelling the market.
North America is expected to hold the majority share of the global Pharmaceuticals & Medicine Manufacturing market during the forecast period.
North America is expected to hold the majority share of the global Pharmaceuticals & Medicine Manufacturing market during the forecast period. An increasing need for diverse pharmaceuticals in the region due to chronic disease prevalence, aging population, and robust R&D environment is responsible for pharmaceuticals & medicine manufacturing market.
Asia Pacific is anticipated to grow at the fastest pace in the global Pharmaceuticals & Medicine Manufacturing market during the forecast period. The region’s rapid urbanization and investments in drug development are supporting the regional market growth. Further, shifting supply chain dynamics and regulatory reforms are responsible for market growth.
Major vendors in the global pharmaceuticals & medicine manufacturing market are F. Hoffmann-La Roche Ltd., Jubilant Pharmova Limited, Novartis AG, Catalent Pharma Solutions, GlaxoSmithKline plc, Lonza, Thermo Fisher Scientific, Inc., Pfizer, Inc., FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Merck & Co., Inc., Samsung Biologics, AstraZeneca, Wuxi Apptec, Johnson & Johnson, Sanofi SA, AbbVie, Inc., Eli Lilly and Company, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In June 2025, CPHI & PMEC China unveiled in Shanghai, forging global pharma manufacturing and sourcing potential.
- In September 2024, Egypt plans to localize drug manufacturing amid global shortages. As global supply chain disruptions continue to threaten access to essential medicines, Egypt has embarked on an ambitious journey to localize drug manufacturing.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Pharmaceuticals & Medicine Manufacturing market based on the below-mentioned segments:
Global Pharmaceuticals & Medicine Manufacturing Market, By Product & Service
- Oncologics & Autoimmune
- Hypertension & Diabetes
- Antiulcerants & Pain
- Dermatology & Antibiotics
- Other
Global Pharmaceuticals & Medicine Manufacturing Market, By Major Market
- Consumers in Developed Markets
- Consumers in Pharmerging Markets
- Consumers in the Rest of the World
Global Pharmaceuticals & Medicine Manufacturing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?